chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10/28 @ 6:30 PM: Left breast hurt, put ice pack on for 30 minutes and then took ice pack off and went to bed without dinner. I slept for 11-12 hours. 10/29 @ 6:30 AM: Woke up for shower. Found rash on breast. Hurt to touch. Rash was also warm to the touch and not raised. Stinging pain occasionally throughout my left breast without touching it. At the time, I had no other symptoms so I went to work. I contacted doctor at 8:45 AM. She said most likely an allergic reaction. She did mention it was weird the rash appeared adjacent to the arm whereas no bruise or extreme pain was at the injection site. She recommended hydrocortisone cream to the rash and to was the size. She also suggested to take Benadryl and Tylenol. I followed her directions. Rash went away by 10/29. Later in the day of 10/29, I received fatigue and nausea.  On both Saturday 10/30 and Sunday 10/31, I felt awful. I had body aches and joint aches that were so severe I could not stand or get out of bed without hurting myself. When standing, I could feel my hip socket grinding against the bone; I had a similar sensation with my tail bone in my spine. I had dry cough, runny nose, congestion, yellow phlegm. My sore throat could not be soothed with neither cold or hot liquids. I became irritable with my unbearable migraines. My eyeballs hurt and I had a sensitivity to light and sound. On 11/1, I had to take the day off of work.
VACCINE EXPOSURE DURING PREGNANCY; This spontaneous pregnancy report received from a patient concerned a 39 year old female. The patient's weight was 247 pounds, and height was 60 inches. The patient's concurrent conditions included: gestational diabetes, and other pre-existing medical conditions included: The patient was pregnant at the time of reporting. The patient experienced drug allergy when treated with dimeticone, and titanium dioxide. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211A21A, expiry: UNKNOWN) dose was not reported, administered on 22-SEP-2021 for prophylactic vaccination. Concomitant medications included insulin aspart for gestational diabetes, and insulin human for gestational diabetes. On 22-SEP-2021, the patient experienced vaccine exposure during pregnancy. The date of the patient's last menstrual period was 01-APR-2021 and expected delivery date was 09-JAN-2022. The pregnancy was continuing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of vaccine exposure during pregnancy was not reported. This report was non-serious.
Anaphylaxis or anaphylactic shock (7 days) B. Encephalopathy or encephalitis (7 days) C. Shoulder Injury Related to Vaccine Administration (7 days) D. Vasovagal syncope (7 days) E. Any acute complications or sequelae
Felt light-headed which then became a headache, lots of joint pain in the hips, knees, and hands. Also had a cough.  No treatment, symptoms disappeared in the morning after night sleep.
Patient reported neck pain 10 minutes post vaccination. Vital sign stable BP 128/78, pulse 78, O2 sat 99%. Patient was monitored for 30 more minutes, patient stated that neck pain has stopped patient was advised to seek medical help if pain (neck) or any other reaction is noted patient in no distress at this time.
Swelling in my left axilla lymph node.  My PCP has scheduled a diagnostic mammogram and axillary ultrasound to rule out any other reasons for the swelling.
Tested positive for COVID-19 after receiving both doses of Moderna vaccine; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19 after receiving both doses of Moderna vaccine) and RHINORRHOEA (Runny nose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for COVID-19 after receiving both doses of Moderna vaccine) and RHINORRHOEA (Runny nose). At the time of the report, COVID-19 (Tested positive for COVID-19 after receiving both doses of Moderna vaccine) and RHINORRHOEA (Runny nose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) positive.         No concomitant medication are provided by reporter.  No treatment medications are provided by reporter.   Reporter did not allow further contact
Patient was been given in the (L) arm when the vaccine ejected out of the junction between needle and syringe and sprayed the patient on the back. She developed urticarial patches on her back within shins. She was given oral BENADRYL tab and reaction subsided. Duration to subside unknown as patient left the clinic.
a little painful and itchy; a little painful and itchy; irregular bright red area on her arm; it hurts not just in the skin but in the muscle as well.; Initially, she had pain in the injection site for 24 hours which then went away; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a little painful and itchy), PRURITUS (a little painful and itchy), ERYTHEMA (irregular bright red area on her arm), MYALGIA (it hurts not just in the skin but in the muscle as well.) and VACCINATION SITE PAIN (Initially, she had pain in the injection site for 24 hours which then went away) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE PAIN (Initially, she had pain in the injection site for 24 hours which then went away). On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (a little painful and itchy), PRURITUS (a little painful and itchy), ERYTHEMA (irregular bright red area on her arm) and MYALGIA (it hurts not just in the skin but in the muscle as well.). On 23-Feb-2021, VACCINATION SITE PAIN (Initially, she had pain in the injection site for 24 hours which then went away) had resolved. At the time of the report, PAIN IN EXTREMITY (a little painful and itchy), PRURITUS (a little painful and itchy), ERYTHEMA (irregular bright red area on her arm) and MYALGIA (it hurts not just in the skin but in the muscle as well.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Medical History was provided by Reporter No Concomitant Medications were  provided by Reporter
Shortness of breath and chest tightness.  Onset 1/21/21 in morning.  Worsened with movement / walking.  Referred to urgent care for immediate medical evaluation
Chills then fever and joint and muscle pain beginning about 12 hours post vaccination and lasting about 24 hours. Dr.  said that this is a common side effect to Covid vaccinations
Heart palpitations occur up to 3 times per day.  Rapid heart rate happened 3 times to date.  Also experienced chest pain which lead me to the ER to be checked for a heart attack.
No adverse event reported. Pt may have received expired vaccine and this is why Rite Aid Pharmacy has me reporting this as a VAERS.
pt vaxed 17OCT94 & 5NOV94 exp epigastralgia; 2 days later exp weakness in legs which gradually inc during the wk; hospitalized on 11NOV94 w/generalized neuropathia in arms/legs bilat peripheral facialis paresis; 21DEC94 pt improving;
Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.; The vaccine was administered to about 9 to 10 patients before the excursion error was discovered; vaccine expired by 1 day; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008c21A and 008c21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day). At the time of the report, PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day) had resolved.            No concomitant medications were reported. No treatment medications were provided by the reporter.   This case was linked to MOD-2021-207778 (Patient Link).
Patient sat down immediately after vaccination in waiting room and starting shaking. Pharmacy staff called 911. Shortly after, the patient stated he was feeling better but then said he was having vision darkness. EMT then came to evaluate patient.
PHN noted redness appearing above and below the injection site within ~5 minutes of injection and extending ~ 2 inches above and below. Recheck of arm 15 minutes later showed it remained the same - client denied any itching or pain. Call to family to assess - related that child did complain of itching that evening and family applied Benadryl cream and there were no further complaints.
I have been having a crawling sensation on both arms and both legs (it feels like something is on my skin but nothing is there) no insect bites are present.; I am still having pain sensations in both my arms at the injection sites.; I am still having pain sensations in both my arms at the injection sites. Sometimes it's a stinging sensation; 05Jun I have had a hard involuntary jerking motion of my left lower leg; I have had some tingling on the left side of my face and my left pointer finger.; This is a spontaneous report from a contactable other hcp. A 56-years-old non pregnancy female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EP7533) dose number unknown via an unspecified route of administration in Arm Left on 05Apr2021 09:30 (age at vaccination 56years old, Pregnant at Time of Vaccination: No) as single dose for covid-19 immunisation. Medical history included sickle cell anaemia from an unknown date and unknown if ongoing. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications in two weeks, prior to the COVID vaccine. The patient's concomitant medications were not reported. Since the vaccination, the patient had been tested positive for COVID-19. On 03May2021 09:00 the patient experienced I have been having a crawling sensation on both arms and both legs (it feels like something is on my skin, but nothing is there) no insect bites are present. I am still having pain sensations in both my arms at the injection sites. Sometimes it's a stinging sensation. June 5th, I have had a hard involuntary jerking motion of my left lower leg and I have had some tingling on the left side of my face and my left pointer finger. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on 10May2021 Nasal Swab. The patient did not receive any treatment for the adverse events. The clinical outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Client is 16 years old and was given MMRV inadvertently. Had previously had MMR and varicella 8/15/2013. Per employee imm program doses are valid.
Narrative:  FATIGUE STARTED ON 1/27/2021 AND GONE AM OF 1/29/2021. LEFT JAW PAIN STARTED 1/28/2021 AND IMPROVED BUT NOT GONE ON 1/29/2021.GOING TO PCM Symptoms:  & PAIN L JAW AND FATIGUE Treatment:
chills & sweating 6hr p/vax;no local rxn;much better now;
Tested positive for COVID19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID19) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced COVID-19 (Tested positive for COVID19). At the time of the report, COVID-19 (Tested positive for COVID19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, COVID-19: positive (Positive) Tested positive for COVID-19 after receiving the first dose of the Moderna vaccine.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact.
PATIENT GOT PALE AND LIGHTHEADED,  AND IMMEDIATELY SAT DOWN.  HE DID PROCEED TO SEIZE FOR 30 SECONDS, AND CAME OUT.  ONCE OUT OF THE SEIZURE PATIENT SEEMED TO COME BACK TO FULL AWARENESS, BUT HAD NO IDEA OF HAVING A SEIZURE.   HE SEEMED TO FULLY RECOVER WHILE HE WAITED BEFORE LEAVING.  HE DID STATE HE HAD NOT EATEN ALL DAY.  HE DID NOT INJURE HIMSELF WHILE SEIZING.
29 weeks pregnant. Intense shivering, coldness started around 2am, woke up at 5:30 with fever of 101.2 and threw up. Sore arm and headache also present. Baby?s movements are unchanged
patient had tingling in his arm down to his hands/patient called dr and dr belived that maybe injection hit a nerve /  patient was called 2 days later and symptoms still persisted but may be improving a little/  md advised to take motrin to decrease swelling/
His blood pressure went extremely low to 88/55; heart rate went to 160; was not a place on his body that did not hurt; charley horses in his legs; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 86-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot Number: EL9264) via intramuscularly on 02Feb2021 at 08:15 as SINGLE DOSE and first dose on 14Jan2021 (Lot number: EL3248) for covid-19 immunisation.The patient's medical history included myocardial infarction (from 2002 to an unknown date Verbatim: Heart attack), prostatic operation (from 2002 to an unknown date Verbatim: Prostate surgery), knee arthroplasty (from Jun2016 to an unknown date Verbatim: Knee replacement), cataract operation (from Feb2013 to an unknown date  Cataract surgery), hypertension (ongoing), cardiac disorder Heart strengthener (ongoing), anticoagulant therapy (ongoing), sinus disorder (ongoing), lung disorder (ongoing), diuretic therapy (ongoing). Concomitant medications included amlodipine (AMLODIPINE) taken for hypertension from an unspecified start date and ongoing; ubidecarenone (COQ-10) taken for cardiac disorder from an unspecified start date and ongoing; (ASPIRIN) taken for anticoagulant therapy from 2002 and ongoing; Ipratropium (IPRATROPIUM) taken for sinus disorder from 2019 and ongoing; cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for sinus disorder from 2019 and ongoing; (FLONASE) taken for sinus disorder from an unspecified start date and ongoing; (BREO) taken for lung disorder from an unspecified start date and ongoing; spironolactone (SPIRONOLACTONE) taken for diuretic therapy from Dec2020 and ongoing; guaifenesin (MUCINEX) taken for lung disorder from Jun2020 and ongoing; leuprorelin acetate (ELIGARD) taken for prostatic specific antigen, neoplasm malignant from an unspecified start date and ongoing; alirocumab (PRALUENT) taken for blood cholesterol from 2018 and ongoing; melatonin (MELATONIN) taken for sleep disorder from 2015 and ongoing. It was reported that, patient was feeling great all day on 02Feb2021. The patient went to bed around 22:00 and at midnight he woke up and there was not a place on his body that did not hurt. He spent the rest of the night hugging a heating pad and had Charlie horses in both of his legs and had to force himself to walk on them. He said that he felt like he played in the super bowl after he got up that morning. He was concerned because the next morning he started having blood pressure activity. His blood pressure went extremely low to 88/55 and heart rate was 160 beats per minute at around 08:30. He took it again at 10:00 and it was 112/75 and pulse was down to 109. It remained at that number pretty stable until around 16:00 and at that time it was like someone upstairs said he was done, he quit hurtling, his blood pressure went back to normal and he felt great again. Outcome of the events was resolved on 03Feb2021.   Follow-up attempts are completed. No further information is expected.
Could not get up off the toilet; severe muscle weakness; went to sleep and woke up on the floor; Could not get up off the floor; A spontaneous report was received from a Consumer concerning a 75 Years old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events include big, red spot on arm, severe muscle weakness, went to sleep and woke up on floor, could not get up off the floor and toilet.  The patient's medical history was not provided. Concomitant medications used by the patient are not provided by the reporter.  On 23 JAN 2021, prior to the onset of the events the patient received one of two planned doses of mRNA-1273 (Batch Number: 028L20A) via intramuscular route on her left arm for prophylaxis of COVID-19 infection.  On 20 FEB 2021, approximately one day prior to the onset of the events the patient received two of two planned doses of mRNA-1273 (Batch Number: 024M20A) via intramuscular route on her left arm for prophylaxis of COVID-19 infection.  Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not provided by the reporter.  The outcome of the listed event related to first dose Big, red spot on arm was said to be unknown. And The outcome of the listed events related to second doses were said to be unknown.
Initial report received on 08 August 2012 from the Investigator participating in the post-marketing study under the reference number M5A16. A case of pertussis disease in a six-month-old male subject was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDS) electronic database. The subject had received 3 doses of PENTACEL; lot number C4145AA received on 23 February and 25 April 2012, and lot number C4230AA received on 26 June 2012 (routes and sites of administration not reported). The subject developed a cough on 12 July 2012, 16 days after receiving the last dose. On 20 July 2012, the subject developed a paroxysmal cough with a whoop. The subject also experienced posttussive vomiting, sleep disturbance and apnea. Laboratory testing included positive PCR on 23 July 2012. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of Azithromycin starting on 23 July 2012 for five days. The subject was not hospitalized. At the time of final contact on 26 July 2012, the subject's cough was still persisting. The duration of the cough was reported at the time as 14 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
A few weeks after my second dose on April 19, I started my period and it just didn't really stop. I wasn't bleeding heavily, just spotty, but it was definitely odd. Since I'm on the pill, I usually bleed for 5-7 days and then I'm done until the next one. I also started getting migraines every day, which usually happens due to extreme fluctuations in hormones. I just dealt with the bleeding and took some migraine meds.
10-13-16 Shot (Flu) felt sick/headache. 10-14- flu symptoms, at doctor. 10-16 - Paralyzed 7:45 am. EMR, Diagnosed GBS. 10-16 - started 5 IVIG treatments.
crying inconsolably for 8-10hr p/vax;ER dept; pt given APAP & cool soaks & massages day of vax;
rheumatoid arthritis; ganglion cysts; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 28-JAN-2014, the patient was vaccinated (inoculated) with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. Subsequently, the patient was treated by a provider for the following injuries resulting from the patient's zoster vaccine live (ZOSTAVAX) use: rheumatoid arthritis, and ganglion cysts (synovial cyst).  The patient claimed damages as result of injury to themselves, and economic losses.The outcome of the events was not provided. Therefore, the causality for the events was related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the event of rheumatoid arthritis was considered to be medically significant.
Can't lift the arm; Hurts so bad; Hard injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE MOVEMENT IMPAIRMENT (Can't lift the arm), ARTHRALGIA (Hurts so bad) and INJECTION SITE PAIN (Hard injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 010M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 19-Feb-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Can't lift the arm), ARTHRALGIA (Hurts so bad) and INJECTION SITE PAIN (Hard injection site). The patient was treated with OXYCODONE at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), VACCINATION SITE MOVEMENT IMPAIRMENT (Can't lift the arm), ARTHRALGIA (Hurts so bad) and INJECTION SITE PAIN (Hard injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
The day of the vaccine I had a initial diarrhea and headache, minimum pain on the site of the injection but at 2AM on the 22nd I woke up from my sleep with chills, and shaking even my teeth were clacking. Took Tylenol and it got better around 30 min later. Felt very fatigued and still nauseated almost threw up. By the end pf the day it resolved itself.